title: Community-acquired extended-spectrum beta-lactamase producers, United States.
authors.forename: Yohei
authors.initials: Y
authors.lastname: Doi
authors.forename: Jennifer
authors.initials: J
authors.lastname: Adams
authors.forename: Alexandra
authors.initials: A
authors.lastname: O'Keefe
authors.forename: Zubair
authors.initials: Z
authors.lastname: Quereshi
authors.forename: Lindsay
authors.initials: L
authors.lastname: Ewan
authors.forename: David L
authors.initials: DL
authors.lastname: Paterson
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000201:enzymology* / Q000378:metabolism; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D001618:beta-Lactamases / Q000096:biosynthesis*
chemical_list: D000900:Anti-Bacterial Agents; D001618:beta-Lactamases